Antifungal Agents Flashcards
Antifungal agent that is nucleic acid synthesis inhibitor
flucytosine
Fungal cell membrane- Fungi use _____________; mammals use cholesterol
Ergosterol
MOA of flucytosine:
A) Actively transported into fungal cells by ______ permease.
B) Converted to ______________ by cytosine deaminase
C) 5-FU is converted to ____________ acid and FUTP.
D) Action is ____________
Cytosine, 5-fluorouracil (5-FU), 5-fluordeoxyuridylic, fungistatic
Antifungal agent: Mitosis Inhibitor
Griseofulvin
MOA of griseofulvin
Binds to tubulin, thereby disrupting assembly of the mitotic spindle; action is fungistatic.
-Accumulates in keratin precursor cells and allows new growth of skin, hair, and nails to be free of fungal infection
Antifungal: Squalene epoxidase Inhibitor
Terbinafine
MOA of Terbinafine
Prevents conversion of squalene to lanosterol, which is precursor to ergosterol- fungicidal
14a-sterol Demethylase Inhibitors- Azoles
Prototype triazole- itraconazole
A fungistatic drug that prevents conversion of lanosterol to ergosterol by causing destabilization of the cell membrane and associated enzymes and increased permeability
Itraconazole- all inhibit 14a-sterol demethylase
Inhibitors of Fungal membrane stability
Amphotericin B and Nystatin
MOA of amphotericin B and nystatin
Forms pores in membrane; allows leakage of cellular contents (K+); action is fungistatic or fungicidal depending on concentration and fungal sensitivity
Inhibitors of fungal cell wall synthesis
caspofungin
Resistance to flucytosine develops how
during therapy when used alone; due to mutations of permease and deaminase
What drug is this: Narrow spectrum agent used to treat systemic candidiasis, cryptococcus neoformans infections, and aspergillus. Usually administered in combination with amphotericin B to increase uptake.
Flucytosine
Flucytosine is ________ absorbed and well distributed; dose reduction is necessary in _________ insufficiency
Orally, renal